600211 logo

Tibet Rhodiola Pharmaceutical Holding Co. Stock Price

SHSE:600211 Community·CN¥13.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

600211 Share Price Performance

CN¥41.70
4.45 (11.95%)
CN¥41.70
4.45 (11.95%)
Price CN¥41.70

600211 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with excellent balance sheet and pays a dividend.

2 Risks
2 Rewards

Tibet Rhodiola Pharmaceutical Holding Co. Key Details

CN¥2.7b

Revenue

CN¥182.7m

Cost of Revenue

CN¥2.5b

Gross Profit

CN¥1.6b

Other Expenses

CN¥981.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
3.04
93.29%
36.07%
24.5%
View Full Analysis

About 600211

Founded
1999
Employees
596
CEO
Yuan Dong Guo
WebsiteView website
www.xzyy.cn

Tibet Rhodiola Pharmaceutical Holding Co. manufactures pharmaceuticals in China and internationally. The company offers biological products, Tibetan medicine, Chinese medicine, and chemical medicine products. It also provides capsules, biological preparations, granules, and film-coating agents for cardiovascular, cerebrovascular, hepatobiliary, sprains and contusions, rheumatism, rheumatoid arthritis, colds, and other fields. The company was founded in 1999 and is based in Lhasa, China.

Recent 600211 News & Updates

Recent updates

No updates